526 Ventures

526 Ventures is a life science venture studio and investment firm based in Cambridge, Massachusetts, that specializes in company creation and early-stage investments within the biotechnology sector. Founded by David Grewal, a former partner at Flagship Pioneering, the firm focuses on identifying breakthrough scientific platforms, particularly in the fields of genetic medicine, RNA therapeutics, and digital health. The firm provides its portfolio companies with strategic leadership, operational expertise, and capital to navigate the transition from concept to clinical development. Notable companies associated with the firm's leadership and investment activity include Aera Therapeutics, Ring Therapeutics, and Tessera Therapeutics. By leveraging a deep network within the biotech ecosystem, 526 Ventures aims to accelerate the translation of scientific innovation into transformative medicines.